184 related articles for article (PubMed ID: 37047797)
1. Stearoyl-CoA Desaturases1 Accelerates Non-Small Cell Lung Cancer Metastasis by Promoting Aromatase Expression to Improve Estrogen Synthesis.
Chen J; Wang Y; Meng W; Zhao R; Lin W; Xiao H; Liao Y
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047797
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.
Huang Q; Wang Q; Li D; Wei X; Jia Y; Zhang Z; Ai B; Cao X; Guo T; Liao Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):129. PubMed ID: 30876460
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
4. BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing metabolic reprogramming via the SCD1/HMGCR module.
Liu L; Chai L; Ran J; Yang Y; Zhang L
Carcinogenesis; 2020 Dec; 41(12):1724-1734. PubMed ID: 32255478
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor activates PI3K/AKT/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis.
Chen J; Zhao R; Wang Y; Xiao H; Lin W; Diao M; He S; Mei P; Liao Y
Mol Med; 2024 Feb; 30(1):28. PubMed ID: 38383297
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody.
Katoh Y; Yaguchi T; Kubo A; Iwata T; Morii K; Kato D; Ohta S; Satomi R; Yamamoto Y; Oyamada Y; Ouchi K; Takahashi S; Ishioka C; Matoba R; Suematsu M; Kawakami Y
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793868
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Stearoyl-CoA Desaturase 1 Potentiates Anti-tumor Activity of Amodiaquine in Non-small Cell Lung Cancer.
Hu X; Xiang J; Li Y; Xia Y; Xu S; Gao X; Qiao S
Biol Pharm Bull; 2022 Apr; 45(4):438-445. PubMed ID: 35110426
[TBL] [Abstract][Full Text] [Related]
8. Decreasing stearoyl-CoA desaturase-1 expression inhibits β-catenin signaling in breast cancer cells.
Mauvoisin D; Charfi C; Lounis AM; Rassart E; Mounier C
Cancer Sci; 2013 Jan; 104(1):36-42. PubMed ID: 23013158
[TBL] [Abstract][Full Text] [Related]
9. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN.
Ran H; Zhu Y; Deng R; Zhang Q; Liu X; Feng M; Zhong J; Lin S; Tong X; Su Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):54. PubMed ID: 29530061
[TBL] [Abstract][Full Text] [Related]
10. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
Song X; Liu J; Liu B; Piao C; Kong C; Li Z
Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
[TBL] [Abstract][Full Text] [Related]
11. EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer.
Zhang J; Song F; Zhao X; Jiang H; Wu X; Wang B; Zhou M; Tian M; Shi B; Wang H; Jia Y; Wang H; Pan X; Li Z
Mol Cancer; 2017 Jul; 16(1):127. PubMed ID: 28724430
[TBL] [Abstract][Full Text] [Related]
12. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
von Roemeling CA; Marlow LA; Wei JJ; Cooper SJ; Caulfield TR; Wu K; Tan WW; Tun HW; Copland JA
Clin Cancer Res; 2013 May; 19(9):2368-80. PubMed ID: 23633458
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
Luyimbazi D; Akcakanat A; McAuliffe PF; Zhang L; Singh G; Gonzalez-Angulo AM; Chen H; Do KA; Zheng Y; Hung MC; Mills GB; Meric-Bernstam F
Mol Cancer Ther; 2010 Oct; 9(10):2770-84. PubMed ID: 20876744
[TBL] [Abstract][Full Text] [Related]
14. Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway.
Gao Y; Li J; Xi H; Cui J; Zhang K; Zhang J; Zhang Y; Xu W; Liang W; Zhuang Z; Wang P; Qiao Z; Wei B; Chen L
Br J Cancer; 2020 Jun; 122(12):1837-1847. PubMed ID: 32350414
[TBL] [Abstract][Full Text] [Related]
15. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
16. SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line.
Lingrand M; Lalonde S; Jutras-Carignan A; Bergeron KF; Rassart E; Mounier C
Breast Cancer; 2020 Jul; 27(4):594-606. PubMed ID: 31993937
[TBL] [Abstract][Full Text] [Related]
17. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
Geng F; Jiang Z; Song X; Zhou H; Zhao H
Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
[TBL] [Abstract][Full Text] [Related]
18. SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma.
Huang J; Fan XX; He J; Pan H; Li RZ; Huang L; Jiang Z; Yao XJ; Liu L; Leung EL; He JX
Oncotarget; 2016 Jun; 7(26):39970-39979. PubMed ID: 27223066
[TBL] [Abstract][Full Text] [Related]
19. Positive feedback loop and synergistic effects between hypoxia-inducible factor-2α and stearoyl-CoA desaturase-1 promote tumorigenesis in clear cell renal cell carcinoma.
Zhang Y; Wang H; Zhang J; Lv J; Huang Y
Cancer Sci; 2013 Apr; 104(4):416-22. PubMed ID: 23331615
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.
Pisanu ME; Noto A; De Vitis C; Morrone S; Scognamiglio G; Botti G; Venuta F; Diso D; Jakopin Z; Padula F; Ricci A; Mariotta S; Giovagnoli MR; Giarnieri E; Amelio I; Agostini M; Melino G; Ciliberto G; Mancini R
Cancer Lett; 2017 Oct; 406():93-104. PubMed ID: 28797843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
